[go: up one dir, main page]

ZA705913B - Inosine derivatives - Google Patents

Inosine derivatives

Info

Publication number
ZA705913B
ZA705913B ZA705913A ZA705913A ZA705913B ZA 705913 B ZA705913 B ZA 705913B ZA 705913 A ZA705913 A ZA 705913A ZA 705913 A ZA705913 A ZA 705913A ZA 705913 B ZA705913 B ZA 705913B
Authority
ZA
South Africa
Prior art keywords
inosine derivatives
inosine
derivatives
Prior art date
Application number
ZA705913A
Other languages
English (en)
Inventor
P Gordon
Original Assignee
Newport Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals filed Critical Newport Pharmaceuticals
Publication of ZA705913B publication Critical patent/ZA705913B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA705913A 1969-08-28 1971-03-26 Inosine derivatives ZA705913B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85386469A 1969-08-28 1969-08-28

Publications (1)

Publication Number Publication Date
ZA705913B true ZA705913B (en) 1971-04-28

Family

ID=25317098

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA705913A ZA705913B (en) 1969-08-28 1971-03-26 Inosine derivatives

Country Status (24)

Country Link
US (1) US3646007A (xx)
JP (2) JPS493999B1 (xx)
AT (1) AT299457B (xx)
BE (1) BE755361A (xx)
BR (1) BR6915483D0 (xx)
CA (1) CA920125A (xx)
CH (1) CH530998A (xx)
CS (1) CS183616B2 (xx)
DE (2) DE1965431C3 (xx)
DK (1) DK137801B (xx)
ES (1) ES375387A1 (xx)
FR (1) FR2068522B1 (xx)
GB (1) GB1252401A (xx)
HU (1) HU162297B (xx)
IL (1) IL35135A (xx)
LU (1) LU61603A1 (xx)
NL (1) NL140735B (xx)
NO (1) NO126800B (xx)
PH (2) PH9221A (xx)
PL (1) PL80960B1 (xx)
SE (1) SE384866B (xx)
SU (1) SU381216A3 (xx)
YU (1) YU36188B (xx)
ZA (1) ZA705913B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2260331B1 (xx) * 1974-02-08 1978-01-13 Mauvernay Centre Europ Rech
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4387226A (en) * 1981-08-26 1983-06-07 Newport Pharmaceuticals International, Inc. Purine-dihydrothiazoles
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
JPS5994567U (ja) * 1982-12-15 1984-06-27 松下電工株式会社 折り畳みドアのラツチ構造
US4512981A (en) * 1982-12-20 1985-04-23 Newport Pharmaceuticals International, Inc. Method of treating inflammation using inosiplex
DE3404315C1 (de) * 1984-02-08 1985-05-09 Newport AG, Zug Verwendung von Inosin-haltigen Wirkstoffen zur Wachstumsfoerderung bei der Mast von Nutztieren
FR2652003A1 (fr) * 1989-09-20 1991-03-22 Delalande Sa Utilisation d'un complexe de l'inosine avec un n,n-dialkylamino alcanol ou un sel de celui-ci avec un acide pharmacologiquement acceptable pour le traitement de certaines infections helminthiques.
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104744541A (zh) * 2014-05-05 2015-07-01 深圳信立泰药业股份有限公司 一种异丙肌苷新晶型、其制备方法及含有该新晶型的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879259A (en) * 1956-11-20 1961-10-11 Riker Laboratories Inc Acid addition salts of 2-dimethylaminoethanol and central nervous system stimulant compositions containing them
US3484521A (en) * 1966-06-23 1969-12-16 Int Chem & Nuclear Corp Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid

Also Published As

Publication number Publication date
JPS4921765B1 (xx) 1974-06-04
CH530998A (de) 1972-11-30
DK137801B (da) 1978-05-08
DK137801C (xx) 1978-10-16
LU61603A1 (xx) 1971-08-05
NL7000574A (xx) 1971-03-02
DE1967073A1 (de) 1976-12-02
SE384866B (sv) 1976-05-24
CA920125A (en) 1973-01-30
PH10011A (en) 1976-07-13
ES375387A1 (es) 1972-05-01
DE1965431A1 (de) 1971-04-08
JPS493999B1 (xx) 1974-01-29
US3646007A (en) 1972-02-29
CS183616B2 (en) 1978-07-31
HU162297B (xx) 1973-01-29
FR2068522B1 (xx) 1974-08-30
DE1967073C2 (de) 1986-04-17
NL140735B (nl) 1974-01-15
IL35135A (en) 1974-07-31
BE755361A (fr) 1971-03-01
YU214570A (en) 1981-04-30
PH9221A (en) 1975-07-10
YU36188B (en) 1982-02-25
IL35135A0 (en) 1970-10-30
NO126800B (xx) 1973-03-26
FR2068522A1 (xx) 1971-08-27
DE1965431B2 (de) 1978-05-18
AT299457B (de) 1972-06-26
SU381216A3 (xx) 1973-05-15
BR6915483D0 (pt) 1973-03-13
PL80960B1 (en) 1975-08-30
DE1965431C3 (de) 1979-01-04
GB1252401A (xx) 1971-11-03

Similar Documents

Publication Publication Date Title
HK61677A (en) Triazolobenzodiazepine derivatives
IL33931A (en) 3-alkylamino-1-phenoxy-2-propanol derivatives
ZA705913B (en) Inosine derivatives
IL34286A0 (en) Melamine derivatives
IL34685A (en) Dibenzodioxocine derivatives
KE2539A (en) Phenylaminoethanol derivatives
PH9290A (en) Tetrahydrocyclopropadibenzazepine derivatives
ZA704940B (en) Propargyl derivatives
MY7500239A (en) Indenopyridine derivatives
ZA704878B (en) Ergoline derivatives
ZA70992B (en) Pyrimidine derivatives
ZA707765B (en) New hydrazinecarbodithioate derivatives
ZA70993B (en) Pyrimidine derivatives
ZA708363B (en) Pyrimidine derivatives
ZA704094B (en) 2-hydroxy-5-benzamide derivatives
ZA705176B (en) Hydroxyisoquinuclidine derivatives
ZA704013B (en) Benzoisothiazol derivatives
ZA706760B (en) Thioazapyrimidine nucleosides
IL34240A0 (en) Imidazole derivatives
AU452977B2 (en) Inosine derivatives
ZA702689B (en) Triazine derivatives
ZA70991B (en) Pyrimidine derivatives
ZA704992B (en) Formamide derivatives
AU7332074A (en) Indenopyridine derivatives
ZA705161B (en) Pyrimidinylpyrazole derivatives